Skip to content

OPEN Foundation

Menu

OPEN Academy
Therapist Training
- ADEPT
- Foundations
  - Curriculum
  - Faculty
  - Enrolment
  - FAQ
Conference
Community
Courses
- Upcoming Events
- Short Courses
Articles & News
About
- Team
- Vacancies
Contact
Donate
Member Login

Search

Articles & News

Search

Search

Scientific Discipline
Substance
Therapeutic Application

"Being with a Buddha": A Case Report of Methoxetamine Use in a United States Veteran with PTSD

January 29, 2017

Prophylactic Ketamine Attenuates Learned Fear

January 27, 2017

Clinical potential of psilocybin as a treatment for mental health conditions

January 1, 2017

Ketamine accelerates fear extinction via mTORC1 signaling

December 30, 2016

Conducting PTSD clinical trials on a Schedule I drug: MDMA

December 12, 2016

Psilocybin: promising results in double-blind trials require confirmation by real-world evidence

December 6, 2016

Psilocybin-assisted psychotherapy for dying cancer patients – aiding the final trip

December 6, 2016

Psilocybin for depression and anxiety associated with life-threatening illnesses

December 6, 2016

The role of psychedelics in palliative care reconsidered: A case for psilocybin

December 1, 2016

Psilocybin and palliative end-of-life care

December 1, 2016

OPEN is a public benefit organisation (ANBI) and registered charity with the Dutch tax authorities.

Linkedin Twitter Facebook-f Instagram Youtube

OPEN

About
Events
Programmes
Resources
Blog
Newsletter
Privacy Policy
Terms & Conditions
Klachtenregeling
Contact

ABOUT

Mission
Team
Partners
FAQs
Nonprofit Status
Financial Reports
Indegeest Network
Working Group GGZ

EVENTS

ICPR Conference
Online Events
On-site Events

RESOURCES

Talks
Papers
Books

PROGRAMMES

Membership
Training
Research

ACTIONS

Participate
Vacancies
Donate

© 2007-2024 OPEN Foundation

Journal Club #29: psychedelic microdosing - Between enhancement and risk: A critical review of psychedelic microdosing - November 3